Blau Farmacêutica, a Brazilian pharmaceutical company listed on Brazilian Stock Market and a regional leader in hospital ...

By CH Unnikrsihnan Drug maker and researcher Glenmark Pharmaceuticals Ltd's new biological drug candidate Bi-Specific ...

As cancer cases climb steadily across India, lower-cost biosimilars like Tishtha could reshape access to life-saving immunotherapy.

Zydus has launched Tishtha, an affordable biosimilar of nivolumab, at nearly one-fourth the original price. Approved by the ...

The launch follows a Delhi High Court nod allowing sales of the cancer drug biosimilar ahead of patent expiry in May 2026.

Get all latest & breaking news on Nipah Virus. Watch videos, top stories and articles on Nipah Virus at moneycontrol.com.

Before Jackson took office at ARPA-H, the agency’s chief data officer departed after disagreeing with the administration’s ...

ADC conjugation, redefined. Explore a rapid 3-hour workflow that delivers precise, controlled antibody-drug conjugates for ...

In a value-led fourth quarter, the Strategy underperformed its core MSCI ACWI benchmark, primarily due to stock selection in the U.S. and Asia Ex Japan.

GSK has agreed to acquire RAPT Therapeutics in a transaction valued at approximately $2.2 billion, adding ozureprubart, a phase IIb long-acting anti-IgE antibody for food allergy prevention, to its ...